FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

33363011000001101: Quinagolide 50microgram tablets and Quinagolide 25microgram tablets (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Sep 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
100756701000001110 Quinagolide 50microgram tablets and Quinagolide 25microgram tablets (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100756801000001118 Quinagolide 50microgram tablets and Quinagolide 25microgram tablets (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Quinagolide 50microgram tablets and Quinagolide 25microgram tablets (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Quinagolide 50microgram tablets and Quinagolide 25microgram tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Quinagolide 50microgram tablets and Quinagolide 25microgram tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Quinagolide 50microgram tablets and Quinagolide 25microgram tablets (Aspire Pharma Ltd) Is a Quinagolide 25micrograms tablet and 50micrograms tablet starter false Inferred relationship Existential restriction modifier
Quinagolide 50microgram tablets and Quinagolide 25microgram tablets (Aspire Pharma Ltd) Has active ingredient Quinagolide true Inferred relationship Existential restriction modifier
Quinagolide 50microgram tablets and Quinagolide 25microgram tablets (Aspire Pharma Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Quinagolide 50microgram tablets and Quinagolide 25microgram tablets (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Quinagolide 50microgram tablets and Quinagolide 25microgram tablets (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Quinagolide 50microgram tablets and Quinagolide 25microgram tablets (Aspire Pharma Ltd) Has dispensed dose form Dose form not applicable (qualifier value) true Inferred relationship Existential restriction modifier
Quinagolide 50microgram tablets and Quinagolide 25microgram tablets (Aspire Pharma Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Quinagolide 50microgram tablets and Quinagolide 25microgram tablets (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Quinagolide 50microgram tablets and Quinagolide 25microgram tablets (Aspire Pharma Ltd) Is a Quinagolide 50microgram tablets and Quinagolide 25microgram tablets false Inferred relationship Existential restriction modifier
Quinagolide 50microgram tablets and Quinagolide 25microgram tablets (Aspire Pharma Ltd) Is a Quinagolide 50microgram tablets and Quinagolide 25microgram tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Quinagolide 50microgram tablets and Quinagolide 25microgram tablets (Aspire Pharma Ltd) 6 tablet 1 x (3 tablets + 3 tablets) Has AMP True Quinagolide 50microgram tablets and Quinagolide 25microgram tablets (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start